跳至主要内容
临床试验/NCT02348463
NCT02348463已完成不适用

Treatment of Bacterial Vaginosis in Early Pregnancy in Skaraborg County in Sweden and the Effect on Spontaneous Preterm Delivery

Skaraborg Hospital0 个研究点目标入组 540 人开始时间: 2007年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
540
主要终点
preterm delivery

研究概览

简要总结

Bacterial vaginosis (BV) is a known risk factor for preterm delivery. This study was conducted in an attempt to investigate if treatment of bacterial vaginosis in early pregnancy could reduce the risk for preterm delivery.

Women were screened for bacterial vaginosis during the first visits at the maternal health care unit with a vaginal sample that were taken by the midwife or by herself. After the vaginal samples was air dried it was sent to the gynaecological department and was investigated using Hay/Ison classification. Eligible women were those who had lived in Skaraborg and delivered at Skaraborg hospital.

详细描述

The study has started 2007 and will continue until 2014. Pregnant women that will come to the maternal health care units in gestational week 8-11 will be offered to be screened for bacterial vaginosis. A vaginal sample will be taken by the midwife or by the women herself. The vaginal sample is air-dried and sent to the gynecological. There it is investigated using Hay/Ison classification for the diagnosis of bacterial vaginosis.

Women with bacterial vaginosis will be offered treatment with topical clindamycin treatment for 7 days if the women has passed the 12th gestational week. A control sample for the test of cure will be done after 10 week. If not cured of BV she will be offered a new treatment.

All women will be followed until delivery.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 52 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant women screened for bacterial vaginosis in early pregnancy

排除标准

  • women not delivered at Skaraborg hospital.

研究组 & 干预措施

treatment of bacterial vaginosis

women with bacterial vaginosis will be offered treatment with clindamycin-2-phosphate

干预措施: Clindamycin-2-phosphate (Drug)

结局指标

主要结局

preterm delivery

时间窗: before 37th week of gestation

次要结局

  • cure of bacterial vaginosis(after 10 weeks)

研究者

发起方
Skaraborg Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Per-Goran Larsson

Professor Consultat

Skaraborg Hospital

相似试验